- Profile
- Personal Information
- Publications
Experts in Clinical Research
Anna Akinshina Elizabeth R. Dumont Alexander R. Gerson Dr. Sateesh B Arja Anita Airee Peter J. Embi N. Elagovan Shaun Grannis Dr. Patricia Rhynders Beulah Shekha Johanne Eliacin Bert van der Zwaan Frank Caligiuri Renae Chesnut Cheryl Clarke Andrew Miesner Dr. David Amor Thomas Felzmann Avihu Boneh John Carlin View MoreKemal Malik
Kemal Malik was appointed to the Board of Manageme
Kemal Malik was appointed to the Board of Management of Baye
Bayer
Viet Nam
Kemal Malik was born in Slough, United Kingdom, on September 29, 1962. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987. Malik subsequently spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions of increasing responsibility in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. Kemal Malik was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division.
Kemal Malik was born in Slough, United Kingdom, on September 29, 1962. He studied medicine at Charing Cross and Westminster Medical School (University of London), graduating as a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1987. Malik subsequently spent several years in clinical medicine at the Northwick Park Clinical Research Centre and at Hammersmith Hospital, London. He then held various positions of increasing responsibility in medical affairs and clinical development at Bristol-Myers Squibb in the United Kingdom. Malik joined Bayer in 1995 as Head of Metabolism and Oncology Europe in the then Pharmaceuticals Business Group. He subsequently served as Head of Global Medical Development before being appointed Head of Global Development. Kemal Malik was a member of the Executive Committee of Bayer HealthCare AG from July 1, 2007 until his appointment to the Board of Management of Bayer AG. He was also Head of Global Development and Chief Medical Officer in the Pharmaceuticals Division.